Use of Osteoporosis Medications after Hospitalization for Hip Fracture: A Cross-national Study
- 3 February 2015
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 128 (5), 519-526.e1
- https://doi.org/10.1016/j.amjmed.2015.01.014
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Making the first fracture the last fracture: ASBMR task force report on secondary fracture preventionJournal of Bone and Mineral Research, 2012
- Direct health-care costs attributed to hip fractures among seniors: a matched cohort studyOsteoporosis International, 2012
- Adherence with intravenous zoledronate and intravenous ibandronate in the United States medicare populationArthritis Care & Research, 2012
- Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidenceJournal of Bone and Mineral Research, 2011
- Bisphosphonates and esophageal cancer—a pathway through the confusionNature Reviews Rheumatology, 2011
- Zoledronic Acid and Clinical Fractures and Mortality after Hip FractureThe New England Journal of Medicine, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisThe New England Journal of Medicine, 2007
- An estimate of the worldwide prevalence and disability associated with osteoporotic fracturesOsteoporosis International, 2006
- Osteonecrosis of the Jaw and BisphosphonatesThe New England Journal of Medicine, 2005
- Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database studyBMJ, 2003